EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Neutrophil–NET Axis in Immune Checkpoint Inhibitor Resistance in Non-Small Cell Lung Cancer: Roles, Biomarkers and Therapeutic Opportunities

Geng Xu iD, Bing Wang iD, Elisa Giovannetti iD

Biomolecules · 2026

DOI: 10.3390/biom16030400 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Geng Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Neutrophils, Lung Neoplasms, Extracellular Traps. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Cancer Society, AIRC IG-grant, Bennink Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related death. Although molecular stratification and multimodal therapy have improved outcomes in selected patients, overall prognosis is still limited by late diagnosis, heterogeneity, and treatment resistance. Immune checkpoint inhibitors (ICIs) have substantially improved survival outcomes in a subset of patients; however, the overall benefit remains limited, and both primary and acquired resistance are common. Neutrophils, as key effectors of innate immune responses, can be activated by diverse stimuli and release neutrophil extracellular traps (NETs). Growing evidence indicates that neutrophils and NETs contribute to remodeling of the tumor microenvironment (TME) in NSCLC, promoting resistance to ICIs. This review systematically summarizes the biological features, key molecular pathways, and inducing factors of neutrophils and NETs in lung cancer and synthesizes evidence supporting their roles as biomarkers of ICI efficacy and prognosis. We further focus on the mechanisms by which NETs mediate immunosuppression and foster an immune-excluded TME, thereby driving resistance to immunotherapy. In addition, we outline potential therapeutic and combination strategies targeting neutrophils and NETs, providing a theoretical basis for developing optimized immunotherapy approaches for NSCLC that target neutrophils and NETs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungNeutrophilsLung NeoplasmsExtracellular TrapsImmune Checkpoint InhibitorsDrug Resistance, NeoplasmBiomarkers, TumorHumansTumor MicroenvironmentAnimalsImmunotherapy

Stichwörter der Autor:innen

immune checkpoint inhibitorsneutrophil extracellular trapsneutrophilsnon-small cell lung cancerresistancetumor microenvironment

Substanzen

Immune Checkpoint InhibitorsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, 1081 HV Amsterdam, The Netherlands.
  • Cancer Pharmacology Laboratory, Fondazione Pisana per la Scienza, Via Ferruccio Giovannini 13, 56017 Pisa, Italy.

ORCID-Profile: Geng Xu, Bing Wang, Elisa Giovannetti

Förderung

  • Dutch Cancer Society
  • AIRC IG-grant
  • Bennink Foundation
  • China Scholarship Council
  • Bennink Foundation and China Scholarship Council

Zitieren

APA

Xu, G., Wang, B., & Giovannetti, E. (2026). The Neutrophil–NET Axis in Immune Checkpoint Inhibitor Resistance in Non-Small Cell Lung Cancer: Roles, Biomarkers and Therapeutic Opportunities. Biomolecules. https://doi.org/10.3390/biom16030400

Vancouver

Xu G, Wang B, Giovannetti E. The Neutrophil–NET Axis in Immune Checkpoint Inhibitor Resistance in Non-Small Cell Lung Cancer: Roles, Biomarkers and Therapeutic Opportunities. Biomolecules. 2026. doi:10.3390/biom16030400

BibTeX
@article{Xu2026,
  author = {Xu, Geng and Wang, Bing and Giovannetti, Elisa},
  title = {The Neutrophil–NET Axis in Immune Checkpoint Inhibitor Resistance in Non-Small Cell Lung Cancer: Roles, Biomarkers and Therapeutic Opportunities},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16030400}
}
Kostenlos starten →